Skip to content
lsd.com
CompletedN/A

The Postoperative Lidocaine and Ketamine Effects on Morphine Requirement in Bariatric Surgery

NCT05591105 · Tiva Group

Closed to entry
Status
Not accepting participants
Not applicable
Phase
64
Target enrolment
1
Study sites
Outside the US

What it is testing

Summary

The goal of this observational study is to evaluate the quality of postoperative analgesia in a group of obese patients schedule to bariatric surgery under TIVA Opiod-free after to receive lidocaine and ketamine perfusion. The main question it aims to answer are: How lidocaine and ketamine perfusion during recovery period does impact over morphine consumption on the following 48 hours after surgery? All participants will receive total intravenous anesthesia and, at the end of the surgery, they will be divided in two groups, group A: placebo and, group B: with postoperative lidocaine and ketamine perfusion. Our hypothesis is ketamine and lidocaine are a good alternative to decrease the use of morphine in obese patients.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Postoperative morphine consumption

    Measured over 48 hours

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 65 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * All patients between 18 y 65 years old. * IMC \> 30 kg/m2 * ASA II/III Exclusion Criteria: * Patients taking high doses of opioids before operation for chronic pain * Patients with allergies to any study medication. * Pregnancy or breastfeeding. * Kidney or heptic failure. * Surgical complication

Where

1 study site

FacilityCityRegionCountry
CarolinaBarcelona—Spain

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT05591105 on ClinicalTrials.gov →

Last updated in the registry 2024-07-03. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits

Substance

Indication